---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-038610"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2026-04-01T23:59:59+00:00"
generated_at: "2026-05-15T07:57:49.863303+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics adds $20M delayed draw term loan facility via credit agreement amendment

## Summary
- Amendment creates $20M delayed draw term loan facility; draws allowed until June 30, 2027 in minimum $10M increments.
- Interest at SOFR + 6.50% (floor 3.25%); company may elect 1.00% PIK; interest-only until August 5, 2029 maturity.
- Company not required to draw; pays 1.00% upfront fee and 0.05% per annum ticking fee.
- Lenders are funds managed by Braidwell LP; Wilmington Trust National Association continues as agent.
- Facility supports disciplined liquidity management and flexible capital deployment.

## SEC filing metadata
- accession: 0001104659-26-038610
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2026-04-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000110465926038610/0001104659-26-038610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000110465926038610/tm2610693d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-038610
- JSON: https://secwatch.observer/filing/0001104659-26-038610.json
- Plain text: https://secwatch.observer/filing/0001104659-26-038610.txt

## Source-grounded claims
- claim_id: 5f4b2a5e1e0a92d85964269b7f7df6c37e5aa9d1
  claim: ORTHOPEDIATRICS CORP amended term loan of not to exceed $20.0 million with Wilmington Trust, National Association at SOFR Interest Rate (with a floor of 3.25%) plus 6.50% maturing August 5, 2029.
  evidence_excerpt: On March 31, 2026, OrthoPediatrics Corp. (the “Company”) and its wholly owned domestic subsidiaries, as borrowers (collectively, the “Credit Parties”), entered into a First Amendment (the “Amendment”) to that certain Credit Agreement and Guaranty (the “Term Loan Agreement”) dated August 5, 2024, by and among the Credit Parties, any additional borrowers from time to time party thereto, any guarantors from time to time party thereto, one or more funds managed by Braidwell LP, as lenders, the other lenders from time to time party thereto, and Wilmington Trust, National Association, as agent. The Amendment provides the Company with incremental committed financing capacity by establishing a new delayed draw term loan facility in an aggregate principal amount not to exceed $20.0 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000110465926038610/0001104659-26-038610-index.htm
- claim_id: a83aff381a1ba892729291728cd6fd856a095fc8
  claim: ORTHOPEDIATRICS CORP amended First Amendment with Braidwell LP valued at $20.0 million (effective 2026-03-31).
  evidence_excerpt: On March 31, 2026, OrthoPediatrics Corp. (the “Company”) and its wholly owned domestic subsidiaries, as borrowers (collectively, the “Credit Parties”), entered into a First Amendment (the “Amendment”) to that certain Credit Agreement and Guaranty (the “Term Loan Agreement”) dated August 5, 2024, by and among the Credit Parties, any additional borrowers from time to time party thereto, any guarantors from time to time party thereto, one or more funds managed by Braidwell LP, as lenders, the other lenders from time to time party thereto, and Wilmington Trust, National Association, as agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000110465926038610/0001104659-26-038610-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.